F3 and cancer: The pathophysiology of such a condition is the capacity of the tumor cells to stimulate the haemostatic system of the host, and this causes the cancer cells to express pro-coagulant proteins such as Cancer Procoagulant, Tissue Factor, and Factor VII, which further causes activation of blood clotting [120].